{"id":756015,"date":"2024-06-19T11:00:42","date_gmt":"2024-06-19T09:00:42","guid":{"rendered":"https:\/\/www.capgemini.com\/fr-fr\/?p=756015"},"modified":"2025-03-04T06:43:37","modified_gmt":"2025-03-04T05:43:37","slug":"essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite","status":"publish","type":"post","link":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","title":{"rendered":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-blogs header-hero-blogs\"><div class=\"container\"><div class=\"hero-blogs\"><div class=\"hero-blogs-content-wrapper\"><div class=\"row\"><div class=\"col-12\"><div class=\"header-title\"><h1>Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9<\/h1><\/div><\/div><\/div><\/div><div class=\"hero-blogs-bottom\"><div class=\"header-author\"><div class=\"author-img\"><img decoding=\"async\" src=\"\/wp-content\/themes\/capgemini2020\/assets\/images\/cg-logo.png?w=200&amp;quality=10\" alt=\"\" loading=\"lazy\"\/><\/div><div class=\"author-name-date\"><h5 class=\"author-name\">Sabrina Ioudarene &amp; Caroline Micheletti Candau<\/h5><h5 class=\"blog-date\">19 juin 2024<\/h5><\/div><\/div><div class=\"brand-image\"><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2020\/assets\/images\/capgemini-engineering-white.svg\" alt=\"capgemini-engineering\"\/><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><h2 class=\"intro-para-title\">Produits \u00e0 partir d\u2019une source biologique (cellule, bact\u00e9rie\u2026), les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques, cellulaires, tissulaires\u2026<br><\/h2><p class=\"intro-para-content\">Pour les laboratoires, les biom\u00e9dicaments repr\u00e9sentent un enjeu colossal, \u00e0 la hauteur de leurs immenses promesses th\u00e9rapeutiques\u2026 \u00e0 condition, bien s\u00fbr, que celles-ci soient confirm\u00e9es par les essais cliniques. Il faut en effet d\u00e9montrer que le m\u00e9dicament fonctionne, mais aussi que son efficacit\u00e9 surpasse celle des traitements d\u00e9j\u00e0 sur le march\u00e9, et cela, sans engendrer d\u2019autres maladies, trop d\u2019effets secondaires, ou des risques sup\u00e9rieurs \u00e0 ses b\u00e9n\u00e9fices. Dans cette course qui n\u2019a qu\u2019un seul vainqueur, il ne suffit donc pas d\u2019avoir mis au point le bon traitement\u00a0: il faut aussi \u00eatre le plus rapide et le plus efficace pour le montrer.<br><br>Lors de l\u2019essai clinique, des patients recrut\u00e9s dans le monde entier re\u00e7oivent, pour certains, le m\u00e9dicament candidat et, pour d\u2019autres, un traitement existant, ou bien un placebo s\u2019il n\u2019y a pas d\u2019\u00e9quivalent. Pour ne pas courir le risque d\u2019une rupture d\u2019approvisionnement qui retarderait l\u2019\u00e9tude, voire l\u2019invaliderait, les laboratoires avaient jusqu\u2019ici pour habitude de constituer de larges stocks de m\u00e9dicaments \u00e0 chaque \u00e9tape du processus, de la fabrication jusqu\u2019aux pharmacies hospitali\u00e8res. Or, cette strat\u00e9gie, qui occasionne des gaspillages importants (70 % de produits inutilis\u00e9s), est de moins en moins soutenable d\u2019un point de vue \u00e9conomique, \u00e9thique (comment, dans un contexte de p\u00e9nurie, justifier d\u2019accumuler des m\u00e9dicaments dont une partie se p\u00e9rimera et sera d\u00e9truite\u00a0?) et environnemental (ces stocks superflus augmentent d\u2019autant les besoins de production, de transport et de stockage, et donc leurs impacts). Surtout, une telle approche n\u2019est plus possible avec les biom\u00e9dicaments, qui sont beaucoup plus co\u00fbteux \u00e0 fabriquer, d\u00e9licats \u00e0 transporter et difficiles \u00e0 conserver (souvent \u00e0 tr\u00e8s basse temp\u00e9rature) que les m\u00e9dicaments de synth\u00e8se. Avec l\u2019arriv\u00e9e de ces nouveaux traitements, il devient donc imp\u00e9ratif d\u2019optimiser la supply chain des essais cliniques autant pour la fiabiliser et l\u2019acc\u00e9l\u00e9rer que pour en minimiser l\u2019empreinte environnementale.<br><\/p><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<h2 class=\"wp-block-heading\" id=\"h-la-cle-de-voute-un-pilotage-strategique-global\">La cl\u00e9 de vo\u00fbte : un pilotage strat\u00e9gique global <\/h2>\n\n\n\n<p>Pour ne pas se contenter d\u2019empiler les stocks de pr\u00e9caution, la priorit\u00e9 est de mettre en place un pilotage strat\u00e9gique global. Ceci va permettre de d\u00e9cloisonner les diff\u00e9rentes \u00e9tapes de la supply cha\u00eene des essais cliniques, de mieux partager les contraintes et les besoins de chacun en amont comme en aval, et ainsi de mieux coordonner chaque niveau. Par exemple, avoir de la visibilit\u00e9 sur diff\u00e9rentes \u00e9tudes permettra de mutualiser les productions et les emballages, que l\u2019on pourra aussi standardiser au maximum. Toujours en ce qui concerne le conditionnement, ce n\u2019est qu\u2019en liaison \u00e9troite avec les exigences du protocole que l\u2019on pourra d\u00e9finir le format et le nombre de doses optimaux. \u00c0 l\u2019inverse, int\u00e9grer les contraintes logistiques lors de la conception de l\u2019\u00e9tude permet, par exemple, de limiter les exp\u00e9ditions. On aura \u00e9galement besoin de cette vision globale pour calculer pr\u00e9cis\u00e9ment, et suffisamment t\u00f4t, les besoins cliniques en tenant compte de tous les param\u00e8tres&nbsp;: pays participants, nombre de patients, protocole, r\u00e8glementation\u2026<\/p>\n\n\n\n<p>Cette approche globale permet aussi de mieux articuler les optimisations propres \u00e0 chaque \u00e9tape&nbsp;: le recours \u00e0 l\u2019\u00e9tiquetage \u00e9lectronique et \u00e0 des mat\u00e9riaux alternatifs pour r\u00e9duire l\u2019impact du packaging&nbsp;; l\u2019\u00e9quilibrage du protocole entre consid\u00e9rations m\u00e9dicales et pratiques pour obtenir les meilleurs r\u00e9sultats possibles&nbsp;; l\u2019optimisation des stocks de m\u00e9dicament comparateur&nbsp;et de leur distribution aux \u00e9tablissements&nbsp;; la gestion, enfin, des \u00e9chantillons biologiques pr\u00e9lev\u00e9s sur les patients pour \u00eatre analys\u00e9s.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-le-numerique-un-outil-indispensable\">Le num\u00e9rique, un outil indispensable<\/h2>\n\n\n\n<p>\u00c0 l\u2019\u00e8re de la bioproduction, l\u2019optimisation de la supply chain passe enfin n\u00e9cessairement par un recours accru aux solutions num\u00e9riques, au premier rang desquels l\u2019IRT (Interactive Response Technology), la pierre angulaire de la gestion des essais cliniques. Les laboratoires vont devoir utiliser \u00e0 plein les riches fonctionnalit\u00e9s de cet outil complexe, ce qui, par manque de ma\u00eetrise, n\u2019est aujourd\u2019hui que rarement le cas. En revanche, il n\u2019existe pas de moteur d\u2019optimisation d\u00e9di\u00e9 \u00e0 cette activit\u00e9, mais Capgemini travaille \u00e0 combler ce manque en adaptant une solution issue du secteur automobile. Enfin, l\u2019IA g\u00e9n\u00e9rative pourrait vite se r\u00e9v\u00e9ler incontournable pour aider tous les acteurs \u00e0 s\u2019orienter face \u00e0 la multiplication des contraintes et des r\u00e9glementations.<\/p>\n\n\n\n<p>\u00c9tant donn\u00e9 le co\u00fbt de d\u00e9veloppement et de production des biom\u00e9dicaments, les laboratoires n\u2019ont pas droit \u00e0 l\u2019erreur. Ils ont imp\u00e9rativement besoin de combiner toutes les solutions \u00e0 leur disposition afin d\u2019optimiser l\u2019ensemble de la cha\u00eene logistique des essais cliniques. Avec des quantit\u00e9s calcul\u00e9es au plus juste, ils minimisent les gaspillages, les besoins de stockage r\u00e9frig\u00e9r\u00e9 et de transport, et donc les impacts environnementaux, tout en garantissant le bon d\u00e9roulement et la qualit\u00e9 de l\u2019\u00e9tude. Les objectifs de durabilit\u00e9 rejoignent ainsi les imp\u00e9ratifs \u00e9conomiques, scientifiques, m\u00e9dicaux et r\u00e9glementaires pour assurer le d\u00e9veloppement et la viabilit\u00e9 de ces nouvelles th\u00e9rapies.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-wrapper-people-slider section section--expert-slider wrapper-people-slider undefined\"><div class=\"container\"><div class=\"content-title\"><h3 data-maxlength=\"34\">Nos expertes<\/h3><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\">\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/03\/people-caroline-micheletti-candau.jpeg\" alt=\"Caroline Micheletti Candau\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Ouvrir dans une nouvelle fen\u00eatre\" href=\"https:\/\/www.linkedin.com\/in\/caroline-micheletti-candau-356a5711\/?originalSubdomain=fr\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Caroline Micheletti Candau<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Global Clinical Supply Chain Leader, Capgemini Engineering<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Ouvrir dans une nouvelle fen\u00eatre\" href=\"https:\/\/www.linkedin.com\/in\/caroline-micheletti-candau-356a5711\/?originalSubdomain=fr\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Apr\u00e8s une formation universitaire en biologie cellulaire, Caroline a travaill\u00e9 chez Sorebio (aujourd\u2019hui Merck Biodevelopment) dans le contr\u00f4le qualit\u00e9. \u00c0 son retour, elle obtient un MBA en administration des affaires, tout en travaillant comme supply chain manager chez Sorebio, avant de rejoindre le monde des essais cliniques, o\u00f9 elle travaille depuis 25 ans. Elle rejoint Capgemini Engineering en 2023, pour d\u00e9velopper l\u2019activit\u00e9 Supply Chain Clinique et le secteur Sciences de la Vie en tant qu\u2019Architecte au sein du bureau avant-vente.<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n\t\t<div class=\"slide\">\n\t\t\t<div class=\"box\">\n\t\t\t\t<div class=\"row\">\n\t\t\t\t\t<div class=\"col-md-6 col-lg-4 box-img-wrapper\">\n\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/03\/people-Sabrina-IOUDARENE.jpg\" alt=\"Sabrina Ioudarene\"\/>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"col-md-6 col-lg-8 box-inner\">\n\t\t\t\t\t\t<div class=\"row title-social-media-header\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 mbl-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Ouvrir dans une nouvelle fen\u00eatre\" href=\"https:\/\/www.linkedin.com\/in\/sabrina-ioudarene-benni-pmp-685561139\/?originalSubdomain=fr\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 box-container\">\n\t\t\t\t\t\t\t\t<div class=\"box-title\">\n\t\t\t\t\t\t\t\t\t<h3 class=\"people-profile-title\">Sabrina Ioudarene<\/h3>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span>Team Manager Life Sciences, Capgemini Engineering<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"col-md-12 col-lg-6 social-box-container dkt-social-icon\">\n\t\t\t\t\t\t\t\t<ul class=\"social-nav\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<li><a aria-label=\"Linkedin\" target=\"_blank\" title=\"Ouvrir dans une nouvelle fen\u00eatre\" href=\"https:\/\/www.linkedin.com\/in\/sabrina-ioudarene-benni-pmp-685561139\/?originalSubdomain=fr\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><\/a><\/li>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"people-info\">Apr\u00e8s un master d\u2019ing\u00e9nieur sp\u00e9cialis\u00e9 en technologie pharmaceutique, Sabrina rejoint le groupe Capgemini en 2006 pour devenir acteur du d\u00e9veloppement de th\u00e9rapies innovantes pour am\u00e9liorer la vie des patients. Elle poss\u00e8de 18 ans d\u2019exp\u00e9rience dans la conduite de projets de R&#038;D Pharma. Fusionnant toutes les comp\u00e9tences qu\u2019elle a d\u00e9velopp\u00e9es, elle est \u00e0 la t\u00eate du centre d\u2019expertise Capgemini Clinical Supply depuis 8 ans. Elle dirige la livraison du portefeuille life science au sein la practsie Manufacturing &#038; Operations. A travers cette fonction, elle d\u00e9veloppe des solutions innovantes pour les soci\u00e9t\u00e9s pharmaceutiques et supervise les projets de Capgemini Life Sciences (qualit\u00e9 de livraison, suivi des projets, satisfaction client et aspects financiers).<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\n<\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Curseur pr\u00e9c\u00e9dent\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Curseur suivant\"><\/button><\/div><\/div><\/section>\n\n\n\n\t\t<section\n\t\t\tclass=\"section section--lifeatcap-learning section--event-slider-careerInvent \">\n\n\t\t\t<div class=\"container\">\n\t\t\t\t<div class='career-invent-header'>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t<div class=\"heading col-12 col-md-8\">\n\t\t\t\t\t\t\t\t<h2>Pour aller plus loin<\/h2>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n\t\t\t<div class=\"slider slider-fader d662f800-b30e-4be3-9341-140dd0b1aa04\">\n\t\t\t\t\t\t\t\t\t<div class=\"slider-nav-wrapper smallDevice\">\n\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 text-center\">\n\t\t\t\t\t\t\t\t<div class=\"slider-nav\">\n\t\t\t\t\t\t\t\t\t<button class=\"slider-prev inactive\"\n\t\t\t\t\t\t\t\t\t\taria-label=\"Curseur pr\u00e9c\u00e9dent\"><\/button>\n\t\t\t\t\t\t\t\t\t<ul class=\"slider-paginator\"><\/ul>\n\t\t\t\t\t\t\t\t\t<button class=\"slider-next \"\n\t\t\t\t\t\t\t\t\t\taria-label=\"Curseur suivant\"><\/button>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div\n\t\t\t\t\tclass=\"slider-list \">\n\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\tclass=\"slide active \">\n\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\tclass=\"slide-bg-wrapper wp-block-cg-blocks-career-invent is-style-sapphire3\">\n\t\t\t\t\t\t\t\t<div class=\"bgImagesection\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bgColor\"><\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"container slide-info-wrapper\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\tclass=\"col-md-6 col-sm-12 box-inner \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bgColor\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tclass=\"content-title \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"explore-header\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tdata-maxlength=\"34\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"POV - Supply Chain des m\u00e9dicaments\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tPOV &#8211; Supply Chain des m\u00e9dicaments\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tclass=\"box-title \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h4 data-maxlength=\"144\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"D\u00e9couvrez les solutions technologiques pour s\u00e9curiser, acc\u00e9l\u00e9rer et optimiser les essais cliniques de bout en bout.\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tstyle=\"white-space: pre-wrap;\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tD\u00e9couvrez les solutions technologiques pour s\u00e9curiser, acc\u00e9l\u00e9rer et optimiser les essais cliniques de bout en bout.\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"brand-logo-wrapper\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrc=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/themes\/capgemini2025\/assets\/images\/Logo_Capgemini_Engineering_white.svg\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\talt=\"Capgemini Engineering\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"btnDiv\"> <a class=\"more2\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tdata-maxlength=\"24\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\taria-label=\"En savoir plus... A propos POV - Supply Chain des m\u00e9dicaments\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"Opens in new window\" tabindex=\"0\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\thref=\"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/publications\/supply-chain-des-medicaments-pour-essais-cliniques\/\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttarget=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tEn savoir plus&#8230;\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a> <\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\n\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-md-6 col-sm-12 text-right box-img-wrapper escaper escaper-right\">\n\t\t\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t\t<picture>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=1200&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=1200&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 1500px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=600&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=1200&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 992px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=400&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=800&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 768px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=400&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg?w=800&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 0)\" \/>\n\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" class=\"box-img\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrc=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/04\/header-POV.jpg\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tstyle=\"object-position: 61% 54%; object-fit: cover;\" alt=\"\" \/>\n\n\t\t\t\t\t\t\t\t\t\t\t\t<\/picture>\n\t\t\t\t\t\t\t\t\t\t\t\t<!-- <img decoding=\"async\" class=\"box-img\" src=\"\"\n\t\t\t\t\t\t\t\t\t\t\tstyle=\"\" alt=\"\"\n\t\t\t\t\t\t\t\t\t\t\/> -->\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"\">\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"slide-reveal\"><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\tclass=\"slide active \">\n\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\tclass=\"slide-bg-wrapper wp-block-cg-blocks-career-invent is-style-sapphire3\">\n\t\t\t\t\t\t\t\t<div class=\"bgImagesection\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bgColor\"><\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"container slide-info-wrapper\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\tclass=\"col-md-6 col-sm-12 box-inner \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bgColor\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tclass=\"content-title \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h3 class=\"explore-header\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tdata-maxlength=\"34\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"France BioLead\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tFrance BioLead\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tclass=\"box-title \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<h4 data-maxlength=\"144\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"Avec France BioLead, faisons de la France, un leader europ\u00e9en de la bioproduction\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tstyle=\"white-space: pre-wrap;\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tAvec France BioLead, faisons de la France, un leader europ\u00e9en de la bioproduction\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"brand-logo-wrapper\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrc=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/themes\/capgemini2025\/assets\/images\/Logo_Capgemini_Engineering_white.svg\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\talt=\"Capgemini Engineering\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"btnDiv\"> <a class=\"more2\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tdata-maxlength=\"24\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\taria-label=\"En savoir plus... A propos France BioLead\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttitle=\"Opens in new window\" tabindex=\"-1\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\thref=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/cas-clients\/avec-france-biolead-faisons-de-la-france-un-leader-europeen-de-la-bioproduction\/\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\ttarget=\"\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tEn savoir plus&#8230;\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/a> <\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\n\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-md-6 col-sm-12 text-right box-img-wrapper escaper escaper-right\">\n\t\t\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t\t<picture>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=1200&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=1200&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 1500px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=600&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=1200&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 992px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=400&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=800&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 768px)\" \/>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<source\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrcset=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=400&amp;quality=90 1x, https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp?w=800&amp;quality=90 2x\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tmedia=\"(min-width: 0)\" \/>\n\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" class=\"box-img\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsrc=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/Banniere-cas-client-france-biolead.webp\"\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tstyle=\"object-position: 61% 54%; object-fit: cover;\" alt=\"\" \/>\n\n\t\t\t\t\t\t\t\t\t\t\t\t<\/picture>\n\t\t\t\t\t\t\t\t\t\t\t\t<!-- <img decoding=\"async\" class=\"box-img\" src=\"\"\n\t\t\t\t\t\t\t\t\t\t\tstyle=\"\" alt=\"\"\n\t\t\t\t\t\t\t\t\t\t\/> -->\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"\">\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"slide-reveal\"><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\n\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t<div class=\"slider-nav-wrapper largeDevice\">\n\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t<div class=\"col-md-12 text-center\">\n\t\t\t\t\t\t\t\t<div class=\"slider-nav\">\n\t\t\t\t\t\t\t\t\t<button class=\"slider-prev inactive\"\n\t\t\t\t\t\t\t\t\t\taria-label=\"Curseur pr\u00e9c\u00e9dent\"><\/button>\n\t\t\t\t\t\t\t\t\t<ul class=\"slider-paginator\"><\/ul>\n\t\t\t\t\t\t\t\t\t<button class=\"slider-next\"\n\t\t\t\t\t\t\t\t\t\taria-label=\"Curseur suivant\"><\/button>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t<\/div>\n\n\t\t<\/section>\n\n\t\t","protected":false},"excerpt":{"rendered":"<p>Produits \u00e0 partir d\u2019une source biologique (cellule, bact\u00e9rie\u2026), les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques, cellulaires, tissulaires\u2026<\/p>\n","protected":false},"author":627,"featured_media":756028,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"{\"uuid\":\"b128b99e-1c80-438b-98bd-8080c098dde3\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"83ad3d1d-68ad-434f-bd08-aa0dbeff9303\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":true,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":true,"_yoast_wpseo_primary_brand":"142","_jetpack_memberships_contains_paid_content":false,"footnotes":"","featured_focal_points":"{\"x\":0.49,\"y\":0.52}"},"categories":[5],"tags":[],"brand":[142],"service":[],"industry":[73],"partners":[],"blog-topic":[396,489],"content-group":[],"class_list":["post-756015","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technologies","brand-capgemini-engineering","industry-life-sciences","blog-topic-engineering","blog-topic-intelligent-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9 - Capgemini France<\/title>\n<meta name=\"description\" content=\"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9\" \/>\n<meta property=\"og:description\" content=\"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini France\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-19T09:00:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-04T05:43:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/webpreview_blog_biomedicaments_durbalite.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9\",\"datePublished\":\"2024-06-19T09:00:42+00:00\",\"dateModified\":\"2025-03-04T05:43:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\"},\"wordCount\":956,\"publisher\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg\",\"articleSection\":[\"Technologies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\",\"name\":\"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9 - Capgemini France\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg\",\"datePublished\":\"2024-06-19T09:00:42+00:00\",\"dateModified\":\"2025-03-04T05:43:37+00:00\",\"description\":\"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg\",\"width\":5472,\"height\":3648,\"caption\":\"Fresh grass with dew drops on blue sky background. Macro\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#website\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/\",\"name\":\"Capgemini France\",\"description\":\"Just another www.capgemini.com site\",\"publisher\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/fr-fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#organization\",\"name\":\"Capgemini France\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png\",\"contentUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png\",\"width\":202,\"height\":60,\"caption\":\"Capgemini France\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9 - Capgemini France","description":"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","og_locale":"fr_FR","og_type":"article","og_title":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9","og_description":"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...","og_url":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","og_site_name":"Capgemini France","article_published_time":"2024-06-19T09:00:42+00:00","article_modified_time":"2025-03-04T05:43:37+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/webpreview_blog_biomedicaments_durbalite.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#article","isPartOf":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/"},"author":{"name":"","@id":""},"headline":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9","datePublished":"2024-06-19T09:00:42+00:00","dateModified":"2025-03-04T05:43:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/"},"wordCount":956,"publisher":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#organization"},"image":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","articleSection":["Technologies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","url":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","name":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9 - Capgemini France","isPartOf":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","datePublished":"2024-06-19T09:00:42+00:00","dateModified":"2025-03-04T05:43:37+00:00","description":"Produits \u00e0 partir d\u2019une source biologique, les biom\u00e9dicaments et les produits biologiques vivants permettent, en compl\u00e9ment des m\u00e9dicaments de synth\u00e8se, de diversifier les traitements et de r\u00e9pondre \u00e0 des besoins m\u00e9dicaux jusque-l\u00e0 insatisfaits\u00a0: vaccins, immunoth\u00e9rapie, th\u00e9rapies g\u00e9niques...","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/#primaryimage","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","contentUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","width":5472,"height":3648,"caption":"Fresh grass with dew drops on blue sky background. Macro"},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/fr-fr\/#website","url":"https:\/\/www.capgemini.com\/fr-fr\/","name":"Capgemini France","description":"Just another www.capgemini.com site","publisher":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/fr-fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.capgemini.com\/fr-fr\/#organization","name":"Capgemini France","url":"https:\/\/www.capgemini.com\/fr-fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png","contentUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png","width":202,"height":60,"caption":"Capgemini France"},"image":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/www.capgemini.com\/fr-fr\/author\/"}]}},"blog_topic_info":[{"id":396,"name":"Engineering"},{"id":489,"name":"Intelligent Industry"}],"taxonomy_info":{"category":[{"id":5,"name":"Technologies","slug":"technologies"}],"brand":[{"id":142,"name":"Capgemini Engineering","slug":"capgemini-engineering"}],"industry":[{"id":73,"name":"Life Sciences","slug":"life-sciences"}],"blog-topic":[{"id":396,"name":"Engineering","slug":"engineering"},{"id":489,"name":"Intelligent Industry","slug":"intelligent-industry"}]},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9","url":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg"},"articleSection":"Technologies","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini France","logo":""},"keywords":[],"dateCreated":"2024-06-19T09:00:42Z","datePublished":"2024-06-19T09:00:42Z","dateModified":"2025-03-04T05:43:37Z"},"rendered":"<meta name=\"parsely-title\" content=\"Essais cliniques des biom\u00e9dicaments\u00a0: une optimisation sous le signe de la durabilit\u00e9\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/fr-fr\/blog\/essais-cliniques-des-biomedicaments-une-optimisation-sous-le-signe-de-la-durabilite\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2024-06-19T09:00:42Z\" \/>\n<meta name=\"parsely-section\" content=\"Technologies\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"jetpack_featured_media_url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","featured_image_alt":"","jetpack-related-posts":[{"id":724005,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/ia-nouveau-moteur-rd-pharma\/","url_meta":{"origin":756015,"position":0},"title":"L\u2019IA, nouveau moteur de la R&amp;D pharmaceutique","author":"cyrille.joseph-lockel@capgemini.com","date":"July 11, 2023","format":false,"excerpt":"Apr\u00e8s des d\u00e9cennies de progr\u00e8s en mati\u00e8re de R&D, beaucoup de laboratoires pharmaceutiques se heurtent \u00e0 un ph\u00e9nom\u00e8ne de d\u00e9croissance de leur retour sur investissement.","rel":"","context":"In &quot;Technologies&quot;","block_context":{"text":"Technologies","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/technologies\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/07\/2023-FR-HFeatured-Image-Blog-IA-Moteur-RD-Pharma.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/07\/2023-FR-HFeatured-Image-Blog-IA-Moteur-RD-Pharma.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/07\/2023-FR-HFeatured-Image-Blog-IA-Moteur-RD-Pharma.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/07\/2023-FR-HFeatured-Image-Blog-IA-Moteur-RD-Pharma.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":791888,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/pour-la-medtech-lavenir-sera-technologique-et-collectif\/","url_meta":{"origin":756015,"position":1},"title":"Pour la Medtech, l\u2019avenir sera technologique et collectif","author":"lucilletavera","date":"October 2, 2025","format":false,"excerpt":"L\u2019industrie des dispositifs m\u00e9dicaux (Medtech) est un secteur foisonnant, \u00e0 la fois fragment\u00e9 et riche d\u2019une grande diversit\u00e9. Y cohabitent quelques acteurs de dimension mondiale et fortement industrialis\u00e9s, une myriade de fabricants tr\u00e8s sp\u00e9cialis\u00e9s et de nombreuses startups innovantes.","rel":"","context":"In &quot;Technologies&quot;","block_context":{"text":"Technologies","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/technologies\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/09\/Banner_blog_medtech.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/09\/Banner_blog_medtech.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/09\/Banner_blog_medtech.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/09\/Banner_blog_medtech.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":713450,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/retail-la-data-levier-cle-pour-optimiser-les-assortiments\/","url_meta":{"origin":756015,"position":2},"title":"Retail\u00a0: la data, levier-cl\u00e9 pour optimiser les assortiments","author":"","date":"March 14, 2023","format":false,"excerpt":"Comment am\u00e9liorer la performance des points de vente sans augmenter le nombre de r\u00e9f\u00e9rences et sans \u2013 trop \u2013 toucher au prix de vente\u00a0?","rel":"","context":"In &quot;Transformation&quot;","block_context":{"text":"Transformation","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/transformation\/"},"img":{"alt_text":"Data et Retail","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/03\/GettyImages-1292406665-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/03\/GettyImages-1292406665-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/03\/GettyImages-1292406665-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/03\/GettyImages-1292406665-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":743204,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/rendre-sa-supply-chain-intelligente-un-enjeu-business-cle-pour-2024\/","url_meta":{"origin":756015,"position":3},"title":"Rendre sa Supply Chain intelligente : un enjeu business cl\u00e9 pour 2024","author":"cyrille.joseph-lockel@capgemini.com","date":"March 1, 2024","format":false,"excerpt":"Alors que les transformations industrielles s\u2019acc\u00e9l\u00e8rent sous une pression prot\u00e9iforme - \u00a0Commerciale \u2013 Environnementale \u2013 R\u00e9glementaire \u2013 R\u00e9silience, les Supply chain doivent s\u2019adapter toujours plus rapidement pour int\u00e9grer des niveaux suppl\u00e9mentaires de complexit\u00e9.","rel":"","context":"In &quot;Transformation&quot;","block_context":{"text":"Transformation","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/transformation\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Featured-Image-Blog-Rendre-sa-supply-chain-intelligente.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Featured-Image-Blog-Rendre-sa-supply-chain-intelligente.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Featured-Image-Blog-Rendre-sa-supply-chain-intelligente.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Featured-Image-Blog-Rendre-sa-supply-chain-intelligente.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":789215,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/leau-un-bien-commun-sous-tension-ia-et-urgence-hydrique\/","url_meta":{"origin":756015,"position":4},"title":"L\u2019eau, un bien commun sous tension\u202f: comment l\u2019Intelligence Artificielle peut aider les entreprises \u00e0 r\u00e9pondre \u00e0 l\u2019urgence hydrique","author":"audreykone","date":"September 8, 2025","format":false,"excerpt":"Selon les pr\u00e9visions des Nations Unies, d\u2019ici 2030, la demande mondiale en eau douce d\u00e9passera de 40 % les capacit\u00e9s disponibles. Cette perspective place les entreprises et les organisations face \u00e0 un double d\u00e9fi : garantir un acc\u00e8s durable \u00e0 l\u2019eau pour leurs activit\u00e9s tout en limitant leur impact sur\u2026","rel":"","context":"In &quot;Transformation&quot;","block_context":{"text":"Transformation","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/transformation\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/07\/Invent-Hackathon-Web.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/07\/Invent-Hackathon-Web.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/07\/Invent-Hackathon-Web.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2025\/07\/Invent-Hackathon-Web.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":727022,"url":"https:\/\/www.capgemini.com\/fr-fr\/perspectives\/blog\/continuite-digitale-compagne-devoir-durabilite\/","url_meta":{"origin":756015,"position":5},"title":"La continuit\u00e9 digitale, levier incontournable pour une industrie durable","author":"cyrille.joseph-lockel@capgemini.com","date":"May 22, 2025","format":false,"excerpt":"L\u2019int\u00e9gration des exigences de durabilit\u00e9 est devenue l\u2019un des enjeux majeurs pour l'ensemble des secteurs industriels. A\u00e9ronautique, automobile, \u00e9nergie, produits de grande consommation\u2026 Tous sont appel\u00e9s \u00e0 r\u00e9\u00e9valuer, au moins en partie, leur impact soci\u00e9tal et environnemental.","rel":"","context":"In &quot;Transformation&quot;","block_context":{"text":"Transformation","link":"https:\/\/www.capgemini.com\/fr-fr\/category\/transformation\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/08\/2023-FR-Featured-Image-Blog-DC-Sustainability.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/08\/2023-FR-Featured-Image-Blog-DC-Sustainability.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/08\/2023-FR-Featured-Image-Blog-DC-Sustainability.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2023\/08\/2023-FR-Featured-Image-Blog-DC-Sustainability.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini France","distributor_original_site_url":"https:\/\/www.capgemini.com\/fr-fr","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/06\/GettyImages-917332300.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/posts\/756015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/users\/627"}],"replies":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/comments?post=756015"}],"version-history":[{"count":7,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/posts\/756015\/revisions"}],"predecessor-version":[{"id":776556,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/posts\/756015\/revisions\/776556"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/media\/756028"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/media?parent=756015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/categories?post=756015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/tags?post=756015"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/brand?post=756015"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/service?post=756015"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/industry?post=756015"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/partners?post=756015"},{"taxonomy":"blog-topic","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/blog-topic?post=756015"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/content-group?post=756015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}